The Safety & Efficacy of Terlipressin vs Octreotide for the Control of Variceal Bleed
Status:
Completed
Trial end date:
2005-07-01
Target enrollment:
Participant gender:
Summary
Terlipressin and Octreotide are two common agents used as adjuvants in the management of
variceal bleeding. Both agents have been claimed equivalent to endoscopic therapy in
randomized studies. There are no head to head clinical trials of these two agents available
in the literature. We aimed to compare the efficacy and safety of Terlipressin and Octreotide
in combination with Endoscopic Variceal band Ligation (EVL)in patients presenting with
Esophageal Variceal Bleed (EVB).